Your browser doesn't support javascript.
loading
Biochemical markers for severity and risk in GBA and LRRK2 Parkinson's disease.
Thaler, Avner; Omer, Nurit; Giladi, Nir; Gurevich, Tanya; Bar-Shira, Anat; Gana-Weisz, Mali; Goldstein, Orly; Kestenbaum, Meir; Cedarbaum, Jesse M; Orr-Urtreger, Avi; Shenhar-Tsarfaty, Shani; Mirelman, Anat.
Afiliação
  • Thaler A; Movement Disorder Unit, Laboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel-Aviv Medical Center, 6 Weizmann Street, 64239, Tel-Aviv, Israel. avnert@tlvmc.gov.il.
  • Omer N; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel. avnert@tlvmc.gov.il.
  • Giladi N; Sagol School of Neuroscience, Tel-Aviv University, Tel Aviv, Israel. avnert@tlvmc.gov.il.
  • Gurevich T; Laboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel-Aviv Medical Center, Tel Aviv, Israel. avnert@tlvmc.gov.il.
  • Bar-Shira A; Movement Disorder Unit, Laboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel-Aviv Medical Center, 6 Weizmann Street, 64239, Tel-Aviv, Israel.
  • Gana-Weisz M; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Goldstein O; Movement Disorder Unit, Laboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel-Aviv Medical Center, 6 Weizmann Street, 64239, Tel-Aviv, Israel.
  • Kestenbaum M; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Cedarbaum JM; Sagol School of Neuroscience, Tel-Aviv University, Tel Aviv, Israel.
  • Orr-Urtreger A; Movement Disorder Unit, Laboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel-Aviv Medical Center, 6 Weizmann Street, 64239, Tel-Aviv, Israel.
  • Shenhar-Tsarfaty S; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Mirelman A; Sagol School of Neuroscience, Tel-Aviv University, Tel Aviv, Israel.
J Neurol ; 268(4): 1517-1525, 2021 Apr.
Article em En | MEDLINE | ID: mdl-33388928

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Neurol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Neurol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel